CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Clinical Outcome of Relapsed or Refractory Burkitt Lymphoma and Mature B-Cell Lymphoblastic Leukemia in Children and Adolescents
Hyery Kim, Eun Sil Park, Soo Hyun Lee, Hong Hoe Koo, Hyo Sun Kim, Chuhl Joo Lyu, So Eun Jun, Young Tak Lim, Hee Jo Baek, Hoon Kook, Ji Won Lee, Hyoung Jin Kang, Kyung Duk Park, Hee Young Shin, Hyeo Seop Ahn
Cancer Research and Treatment. 2014;46(4):358-365.   Published online 2014 July 21    DOI: https://doi.org/10.4143/crt.2013.047

Excel Download

ALL-315: Outcome of Adults with Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Clinical Lymphoma Myeloma and Leukemia. 2020;20:S170   Crossref logo
Link1 Link2

Clinical Outcome of Relapsed or Refractory Burkitt Lymphoma and Mature B-Cell Lymphoblastic Leukemia in Children and Adolescents
Cancer Research and Treatment. 2014;46(4):358-365   Crossref logo
Link1 Link2

Blinatumomab: Bridging the Gap in Adult Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia
Clinical Lymphoma Myeloma and Leukemia. 2016;16:S2-S5   Crossref logo
Link1 Link2

Use of Bortezomib in Pediatric Relapsed/Refractory Acute Lymphoblastic Leukemia
Clinical Lymphoma Myeloma and Leukemia. 2017;17:S269-S270   Crossref logo
Link1 Link2

ALL-056: Outcome of Relapsed or Refractory Acute B-Lymphoblastic Leukemia Patients with Extramedullary Disease Receiving Inotuzumab Ozogamicin
Clinical Lymphoma Myeloma and Leukemia. 2021;21:S265   Crossref logo
Link1 Link2

Rituximab in three children with relapsed/refractory B-cell acute lymphoblastic leukaemia/Burkitt non-Hodgkin's lymphoma
British Journal of Haematology. 2004;125(3):414-415   Crossref logo
Link1 Link2 Link3

Poster: ALL-056: Outcome of Relapsed or Refractory Acute B-Lymphoblastic Leukemia Patients with Extramedullary Disease Receiving Inotuzumab Ozogamicin
Clinical Lymphoma Myeloma and Leukemia. 2021;21:S206   Crossref logo
Link1 Link2

Novel Treatment Approaches in Relapsed/Refractory Mantle Cell Lymphoma
Clinical Lymphoma Myeloma and Leukemia. 2021;21:S187-S188   Crossref logo
Link1 Link2

Relapsed or Refractory Lymphoblastic Lymphoma in Children: Results and Analysis of 23 Patients in the EORTC 58951 and the LMT96 Protocols
Pediatric Blood & Cancer. 2016;63(7):1214-1221   Crossref logo
Link1 Link2

Nelarabine in Adult Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia/Lymphoma(T-ALL/T-LBL): The Mayo Clinic Experience
Clinical Lymphoma Myeloma and Leukemia. 2017;17:S253-S254   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.